AstraZeneca PLC

AstraZeneca PLC is a multinational pharmaceutical and biotechnology company headquartered at the Cambridge Biomedical Campus in Cambridge, United Kingdom. It focuses on researching, developing, manufacturing, and commercializing innovative medicines and vaccines across key therapeutic areas including oncology, biopharmaceuticals, cardiovascular, renal, metabolism, respiratory, immunology, rare diseases, and infection. The company maintains major research and development centers in Cambridge, UK; Gaithersburg, Maryland, US; Gothenburg, Sweden; and Warsaw, Poland, supporting a pipeline that addresses cancer, cardiovascular diseases, kidney diseases, influenza, and other conditions. AstraZeneca PLC delivers products for primary care, specialty care, and global health initiatives, with operations spanning innovative medicines and biologics. Its portfolio emphasizes treatments for respiratory inflammation, autoimmune disorders, gastrointestinal issues, neuroscience, and vaccines, contributing to advancements in non-communicable diseases and access programs in various regions worldwide. Founded in 1999, AstraZeneca PLC plays a significant role in the global biopharmaceutical market through its comprehensive therapeutic focus and strategic R&D investments.